Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement
Clinical trial NCT00408239 · COMPLETED
Trial details
- NCT number
- NCT00408239
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2009-03-01
- Enrollment
- 367
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.